An interesting mouse model that remains to be established will be to cross existing mt-Keima mice that were established to measure mitophagy efficiency in vivo (290) with mice models reproducing neurodegenerative diseases such as ALS (i.e., A53T α-synuclein transgenic mice). Here, SNCA is linked to neurodegenerative disease.